A critical advance in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This vital cancer suppressor protein is frequently lost in various types of malignancies, leading uncontrolled cell https://bookmark-vip.com/story22059322/mini-antibodies-reactivate-tumor-suppressor-p53-new-new-approach-for-tumor-treatment